SCHEMBL13898488

SCHEMBL13898488

c1ccc(C2=NCc3ccsc32)cc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NOS2 P35228 3/20 0.37
NOS3 P29474 2/20 0.37
PDPK1 O15530 1/20 0.37
GABRA1 P14867 2/20 0.36
GABRG2 P18507 2/20 0.36
GABRB3 P28472 2/20 0.36
GABRA5 P31644 2/20 0.36
GABRA3 P34903 2/20 0.36
GABRA2 P47869 2/20 0.36
GABRB2 P47870 2/20 0.36
CASP3 P42574 1/20 0.34
CCKBR P32239 1/20 0.34
CHRM1 P11229 3/20 0.34
ALDH1A1 P00352 2/20 0.34
PKM P14618 1/20 0.34
HTT P42858 1/20 0.34
NPSR1 Q6W5P4 1/20 0.34
ADORA2A P29274 1/20 0.33
KDM4E B2RXH2 1/20 0.33
MEN1 O00255 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2980218 0.82 NOS3 (0.54) NOS2NOS3PDPK1
SCHEMBL7379267 0.74 BCAT2 (0.37) NOS2NOS3PDPK1GABRA1GABRG2
SCHEMBL7318231 0.73 GABRA1 (0.60) GABRA1GABRG2GABRB3GABRA5GABRA3
SCHEMBL7311296 0.72 GABRA1 (0.34) PDPK1GABRA1GABRG2GABRB3GABRA5
SCHEMBL11405163 0.66 KMT2A (0.40) PDPK1CASP3ALDH1A1KDM4EMEN1
SCHEMBL28446484 0.64 IDO1 (0.43) NOS2NOS3GABRA1GABRG2GABRB3
SCHEMBL26234520 0.63 GABRA1 (0.42) GABRA1GABRG2GABRB3GABRA5GABRA3
SCHEMBL3128983 0.63 PTGS2 (0.41) PDPK1CASP3ALDH1A1ADORA2AKDM4E
SCHEMBL17807492 0.62 NOS2 (0.53) NOS2NOS3PDPK1GABRA1GABRG2
SCHEMBL2282129 0.61 NISCH (0.44) GABRA1GABRG2GABRB3GABRA5GABRA3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7511046-B2 Thienoisoxazolyl- and thienylpyrrazolyl-phenoxy substituted propyl derivatives useful as D4 antagonists AVENTIS HOKLINGS INC. (US) 2009-03-31 US disclosed
US-20070004695-A1 THIENOISOXAZOLYL-AND THIENYLPYRRAZOLYL PHENOXY SUBSTITUTED PROPYL DERIVATIVES USEFUL AS D4 ANTAGONISTS AVENTIS PHARMACEUTICALS INC. (US) 2007-01-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070004695-A1 THIENOISOXAZOLYL-AND THIENYLPYRRAZOLYL PHENOXY SUBSTITUTED PROPYL DERIVATIVES USEFUL AS D4 ANTAGONISTS DRD4, DRD2, SLC6A3 NOS2 4491/4885NOS3 3679/4885PDPK1 1031/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.